Member Info for aspex

Sorry. Should have been 5000+ !

Baza,

500+ posts.

Request. Please stop trying to interview your keyboard and reporting the result to everyone else who have long lost any interest.

Net, indeed but the my slow typing gets in the way. ;-))

Baz, I am hopeful but none of us can yet find any clues except that there is a company obligation to reveal ………

Carry on regardless or is that rewardless?

A personal chat between net and Baz may amuse but any progress on recent commentary has yet to emerge.

Carry on you two but I would prefer to not have to come here to try and sift through dross in the hope of finding even the tiniest jewel.

Uniilever still has a disadvantage against Croda because they do market their own products at retail level .

Some would conflict with true cosmetics brands.

Croda are probably limited by policy not to compete with their customers.

Their base mixes that they are offering are presumably to small volume brands connecting to a specific/local market.

I see the Zenakine product as having major advantage against others as their proprietary ownership generating a reluctance of any competitors to adopt.

If that is right Zenakine is immediately available to all customers on Croda’s books knowing that it can be added/substituted “ next week” and restricted only by marketing policy or budget.

Bazaar

I really, really believe your message has got through…

got through….

got through….

got through….

got through….

Ta.

got through….

One way to see the NDA reveal is that ‘a reason to sell’ is just as powerful as ‘a reason not to sell’.

Full future potential is needed to make a decision unless the holder Is here just to trade.

Personally I would rather SOH hocked off Probiotix shares than the remaining SBTX.

Then I assume that under Aquis those shares are both sticky and under priced compared to the alternative AIM listing option.

That was his decision at the time and we live with it.

Fantastic article by the crew.

Just hope it comes to pass.

Just musing over the fall from the peak.

How many shares have been given a specific target so many months ahead?

The ‘hot money’ has been given plenty of time to get their bets on and the usual crowded exit.

What were we expecting?

Given the new opportunity to evaluate the unexpected potential market that is now revealed, some of us may reevaluate whether current positions can be taken further.

Right now Opti holdings of SBTX spread over 97.94 million shares plus perhaps SOH options of 6.1million would result in 194 SBTX shares for every 1000 holding in OPTI.

Message to SOH “Do not squander them!”

As my transactions always occur with a U designation, I assume these are cleared using the auction balancing which can occur multiple times each day. many quite large trades seem to use this method.

But then what do I know?

Now really is the time that the remaining holding must stay intact.

SOH could easily ‘show the faith’ by converting a few of his 16p options out of his not insignificant salary.

Other ideas?

If Opti still has close to 25m shares then even with the free carry options of SOH then each 1p rise in SBTX is in excess of 0.2p per Opti share. Various guesstimates by enthusiastic holders of SBTX see the share price reaching three figures within a year or so.

Then there is the PBX price if it is still held by Opti.

…and leaving the shares with Aquis making liquidity unnecessarily tight….

We know the ever optimistic SOH but in his comments he mentions this “as the first of a number of launches planned with partners in the USA”

Ten tonnes of Slimbiome in first year!

Sorry but blameless for those but recently did a couple at x30000